Literature DB >> 20970362

Analysis of ACTA2 in European Moyamoya disease patients.

Constantin Roder1, Vera Peters, Hidetoshi Kasuya, Tsutomu Nishizawa, Sho Wakita, Daniela Berg, Claudia Schulte, Nadia Khan, Marcos Tatagiba, Boris Krischek.   

Abstract

The discovery of common genetic patterns in different system vascular diseases may provide important insights into the pathogenesis of these severe medical conditions. Recently, the coincidence of mutations in ACTA2 (vascular smooth muscle cell specific isoform of α-actin) in families with thoracic aortic aneurysms and dissections (TAAD) and Moyamoya disease (MMD) was reported in patients of Northern European descent and a positive family history for TAAD and MMD. In this study, we analyzed the nine exons of the ACTA2 gene in central European patients with non-familial MMD, aiming to replicate previously described genetic findings and possibly identify further mutations. DNA sequencing of the nine exons and flanking intronic regions of ACTA2 was performed in 39 MMD patients with no family history for MMD or TAAD and 68 healthy controls of central European descent with custom made primers. One new mutation (R179H, heterozygous) in exon 6 of ACTA2 was found in one patient with MMD. We were not able to detect other previously described mutations. In contrast to a previous report, we did not identify significant sequence variations in ACTA2. Further combined analysis of ACTA2 and other, possibly causative, genes in larger cohorts of MMD and other vascular diseases may identify possible common disease-causing mechanisms.
Copyright © 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970362     DOI: 10.1016/j.ejpn.2010.09.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  14 in total

1.  Genomewide association study identifies no major founder variant in Caucasian moyamoya disease.

Authors:  Wanyang Liu; S T M L D Senevirathna; Toshiaki Hitomi; Hatasu Kobayashi; Constantin Roder; Roman Herzig; Markus Kraemer; Maurits H J Voormolen; Pavlína Cahová; Boris Krischek; Akio Koizumi
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

Review 2.  Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.

Authors:  Carolina Araujo Moreno; Konradin Metze; Elizete Aparecida Lomazi; Débora Romeo Bertola; Ricardo Henrique Almeida Barbosa; Viviana Cosentino; Nara Sobreira; Denise Pontes Cavalcanti
Journal:  Am J Med Genet A       Date:  2016-08-02       Impact factor: 2.802

3.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.

Authors:  Snaigune Miskinyte; Matthew G Butler; Dominique Hervé; Catherine Sarret; Marc Nicolino; Jacob D Petralia; Francoise Bergametti; Minh Arnould; Van N Pham; Aniket V Gore; Konstantinos Spengos; Steven Gazal; France Woimant; Gary K Steinberg; Brant M Weinstein; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2011-05-19       Impact factor: 11.025

Review 4.  Matrix-dependent perturbation of TGFβ signaling and disease.

Authors:  Jefferson J Doyle; Elizabeth E Gerber; Harry C Dietz
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

5.  A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations.

Authors:  Pinki Munot; Dawn E Saunders; Dianna M Milewicz; Ellen S Regalado; John R Ostergaard; Kees P Braun; Timothy Kerr; Klaske D Lichtenbelt; Sunny Philip; Christopher Rittey; Thomas S Jacques; Timothy C Cox; Vijeya Ganesan
Journal:  Brain       Date:  2012-07-24       Impact factor: 13.501

Review 6.  Genetics of hereditary large vessel diseases.

Authors:  Takayuki Morisaki; Hiroko Morisaki
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

7.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD.

Authors:  Marjolijn Renard; Bert Callewaert; Machteld Baetens; Laurence Campens; Kay MacDermot; Jean-Pierre Fryns; Maryse Bonduelle; Harry C Dietz; Isabel Mendes Gaspar; Diogo Cavaco; Eva-Lena Stattin; Constance Schrander-Stumpel; Paul Coucke; Bart Loeys; Anne De Paepe; Julie De Backer
Journal:  Int J Cardiol       Date:  2011-09-19       Impact factor: 4.164

Review 8.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

10.  Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.

Authors:  Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg
Journal:  G3 (Bethesda)       Date:  2015-11-03       Impact factor: 3.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.